Heart Valve Prosthesis-Patient Mismatch

NCT ID: NCT00629902

Last Updated: 2008-05-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-02-29

Study Completion Date

2008-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the frequency of prosthesis-patient mismatch after mitral valve replacement and its effect on clinical outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Mitral valve replacement (MVR) is associated with higher short and long term mortality than aortic valve replacement or mitral valve repair. The suboptimal results of MVR underline the importance of identifying and preventing prosthesis- patient mismatch. The effective orifice area (EOA) of prosthetic valves used for MVR is often too small in relation to body size, thus causing a mismatch between valve EOA and transvalvular flow. As a consequence, normally functioning mitral prostheses often have relatively high gradients that are similar to those found in patients with mild to moderate mitral stenosis. Residual pressure gradients across mitral prostheses delay the regression of left atrial and pulmonary arterial hypertension. Pulmonary hypertension may cause rightsided failure and is an important risk factor for morbidity and mortality in patients with cardiovascular diseases. However data about the frequency of prosthesis-patient mismatch after mitral valve replacement and its effect on clinical outcome is inconclusive. Predetermined outcomes will be evaluated in the clinical course of this condition.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Valve Diseases

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Heart valve prosthesis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A1

Patients with prosthesis-patient mismatch after mitral valve replacement

No interventions assigned to this group

A2

Patients without prosthesis mismatch after mitral valve replacement

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients \> 18 years with a clinical condition of mitral valve prosthesis

Exclusion Criteria

* Evidence of prosthesis valve dysfunction (dehisence, endocarditis or thrombus of prosthetic mitral valve)
* Concomitant aortic valve prosthesis and tricuspid valve prosthesis
* Presence of \> +2 aortic valve regurgitation and/or mild aortic stenosis
* Prosthetic mitral valve replacement operation \< 6 months
* Left ventricular ejection fraction \< 50%
* Chronic obstructive pulmonary disease
* Concomitant hypertrophic cardiomyopathy, atrial septal defect
* Patients with poor ehocardiographic window
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Florence Nightingale Hospital, Istanbul

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Florence Nightingale Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Saide Aytekin, Professor

Role: PRINCIPAL_INVESTIGATOR

T.C. Istanbul Bilim University, Medical Faculty, Florence Nightingale Hospital, Division of Cardiology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

T.C. Bilim University, Medical Faculty, Florence Nightingale Hospital, Division of Cardiology

Istanbul, Sisli, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Totaro P, Argano V. Patient-prosthesis mismatch after mitral valve replacement: myth or reality? J Thorac Cardiovasc Surg. 2007 Sep;134(3):697-701. doi: 10.1016/j.jtcvs.2007.04.031.

Reference Type BACKGROUND
PMID: 17723820 (View on PubMed)

Li M, Dumesnil JG, Mathieu P, Pibarot P. Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement. J Am Coll Cardiol. 2005 Apr 5;45(7):1034-40. doi: 10.1016/j.jacc.2004.10.073.

Reference Type BACKGROUND
PMID: 15808760 (View on PubMed)

Magne J, Mathieu P, Dumesnil JG, Tanne D, Dagenais F, Doyle D, Pibarot P. Impact of prosthesis-patient mismatch on survival after mitral valve replacement. Circulation. 2007 Mar 20;115(11):1417-25. doi: 10.1161/CIRCULATIONAHA.106.631549. Epub 2007 Mar 5.

Reference Type BACKGROUND
PMID: 17339554 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AT-1974

Identifier Type: -

Identifier Source: org_study_id